ÆÄÀÌÇÁ¶óÀÎ ºÐ¼® ½ÃÀåÀ» Á¶»ç ºÐ¼®ÇÑ ÀÚ·á·Î ½ÃÀå±Ô¸ð, »ê¾÷ºÐ¼®, ÇâÈÄ ½ÃÀå¿¹Ãø µîÀÇ ³»¿ëÀ» ´Ù·ç°í ÀÖ½À´Ï´Ù.
![]() |
¼¼°èÀÇ ¸²ÇÁÁ¾ Ç×ü ¾à¹° Á¢ÇÕÁ¦ ½ÃÀå : ±âȸ, ƯÇã, °¡°Ý, ½ÂÀÎ ¾à¹°ÀÇ ¸ÅÃâ°ú ÀÓ»ó½ÃÇè µ¿Çâ(2030³â)
Global Lymphoma Antibody Drug Conjugates Market Opportunity, Patent, Price, Approved Drug Sales & Clinical Trials Insight 2030
¹ßÇà 2025³â 10¿ù
°¡°Ý
US $ 3,000
![]() |
![]() |
À¯À×À°Á¾ ½ÃÀå - ¼¼°è ¹× Áö¿ªº° ºÐ¼® : Áö¿ªº° - ºÐ¼®°ú ¿¹Ãø(2025-2035³â)
Ewing Sarcoma Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035
¹ßÇà 2025³â 09¿ù
°¡°Ý
US $ 4,900
![]() |
![]() |
Áã ³ú µµÆÄ¹Î ½Å°æ ¿µ¾çÀÎÀÚ ½Ã¾à ½ÃÀå º¸°í¼ : µ¿Çâ, ¿¹Ãø, °æÀï ºÐ¼®(-2031³â)
Rat Brain Dopamine Neurotrophic Factor Reagent Market Report: Trends, Forecast and Competitive Analysis to 2031
¹ßÇà 2025³â 09¿ù
°¡°Ý
US $ 3,850
![]() |
![]() |
ÇÏÀÎµÎ¾Ï Ä¡·á ½ÃÀå º¸°í¼ : µ¿Çâ, ¿¹Ãø, °æÀï ºÐ¼®(-2031³â)
Hypopharyngeal Cancer Treatment Market Report: Trends, Forecast and Competitive Analysis to 2031
¹ßÇà 2025³â 09¿ù
°¡°Ý
US $ 3,850
![]() |
![]() |
½Ç·Î½Ãºó º¸Á¶¿ä¹ý ½ÃÀå º¸°í¼ : µ¿Çâ, ¿¹Ãø, °æÀï ºÐ¼®(-2031³â)
Psilocybin Assisted Therapy Market Report: Trends, Forecast and Competitive Analysis to 2031
¹ßÇà 2025³â 09¿ù
°¡°Ý
US $ 3,850
![]() |
![]() |
¼¼°èÀÇ ¿ø¹ß¼º ´ãÁó¼º ´ã°ü¿° ½ÃÀå º¸°í¼(2025³â)
Primary Biliary Cholangitis Global Market Report 2025
¹ßÇà 2025³â 09¿ù
°¡°Ý
US $ 4,490
![]() |
![]() |
¼¼°èÀÇ °¥»ö¼¼Æ÷Á¾ ½ÃÀå º¸°í¼(2025³â)
Pheochromocytoma Global Market Report 2025
¹ßÇà 2025³â 09¿ù
°¡°Ý
US $ 4,490
![]() |
![]() |
¼¼°èÀÇ ºñ°áÇÙ¼º Ç×»ê±Õ(NTM) °¨¿°Áõ ½ÃÀå º¸°í¼(2025³â)
Nontuberculous Mycobacterial Infection Global Market Report 2025
¹ßÇà 2025³â 09¿ù
°¡°Ý
US $ 4,490
![]() |
![]() |
¼¼°èÀÇ ¹éÇ÷±¸ ºÎÂø °áÇÌÁõ °ü¸® ½ÃÀå º¸°í¼(2025³â)
Leukocyte Adhesion Deficiency Management Global Market Report 2025
¹ßÇà 2025³â 09¿ù
°¡°Ý
US $ 4,490
![]() |
![]() |
¼¼°èÀÇ °£Áú¼º ¹æ±¤¿° ½ÃÀå º¸°í¼(2025³â)
Interstitial Cystitis Global Market Report 2025
¹ßÇà 2025³â 09¿ù
°¡°Ý
US $ 4,490
![]() |
![]() |
¼¼°èÀÇ °ü»óµ¿¸Æ Áúȯ ½ÃÀå º¸°í¼(2025³â)
Coronary Artery Disease Global Market Report 2025
¹ßÇà 2025³â 09¿ù
°¡°Ý
US $ 4,490
![]() |
![]() |
±Û·çÄ«°ï À¯»çÆéƼµå 1(GLP-1) ½ÃÀå ºÐ¼®°ú ¿¹Ãø : À¯Çüº°, Á¦Ç°º°, ¼ºñ½ºº°, ±â¼úº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Àü°³º°, µð¹ÙÀ̽ºº°, ÇÁ·Î¼¼½ºº°
GLP 1 Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Application, End User, Deployment, Device, Process
¹ßÇà 2025³â 09¿ù
°¡°Ý
US $ 4,750
![]() |
![]() |
¼¼°èÀÇ ¹éÇ÷º´ ¾ïÁ¦ ÀÎÀÚ(LIF) ½ÃÀå º¸°í¼(2025³â)
Leukemia Inhibitory Factor (LIF) Global Market Report 2025
¹ßÇà 2025³â 09¿ù
°¡°Ý
US $ 4,490
![]() |
![]() |
¼¼°èÀÇ »ý½Ä»ùÀÚ±ØÈ£¸£¸ó ºÐºñ È£¸£¸ó(GnRH) ¼ö¿ëü ±æÇ×Á¦ ½ÃÀå º¸°í¼(2025³â)
Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonists Global Market Report 2025
¹ßÇà 2025³â 09¿ù
°¡°Ý
US $ 4,490
![]() |
![]() |
¼¼°èÀÇ °í³ªµµÆ®·ÎÇÉ ¹æÃâ È£¸£¸ó(GnRH) ÀÛ¿ëÁ¦ ¹× ±æÇ×Á¦ ½ÃÀå º¸°í¼(2025³â)
Gonadotropin-Releasing Hormone (GnRH) Agonists And Antagonists Drugs Global Market Report 2025
¹ßÇà 2025³â 09¿ù
°¡°Ý
US $ 4,490
![]() |
![]() |
¼¼°èÀÇ Ä®½ÃÅä´Ñ À¯ÀüÀÚ °ü·Ã ÆéŸÀÌµå ¼ö¿ëü ±æÇ×Á¦ ½ÃÀå º¸°í¼(2025³â)
Calcitonin Gene-Related Peptide Receptor Antagonist Global Market Report 2025
¹ßÇà 2025³â 09¿ù
°¡°Ý
US $ 4,490
![]() |
![]() |
¼¼°èÀÇ ºÎÆ®¸®½Ã¶õ(Vutrisiran) ½ÃÀå º¸°í¼(2025³â)
Vutrisiran Global Market Report 2025
¹ßÇà 2025³â 09¿ù
°¡°Ý
US $ 4,490
![]() |
![]() |
¼¼°èÀÇ CD40 ¸®°£µå(CD40L) Ç×ü ½ÃÀå º¸°í¼(2025³â)
CD40 Ligand (CD40L) Antibody Global Market Report 2025
¹ßÇà 2025³â 09¿ù
°¡°Ý
US $ 4,490
![]() |
![]() |
¿À·º½Å ±æÇ×Á¦ ½ÃÀå º¸°í¼ : µ¿Çâ, ¿¹Ãø, °æÀï ºÐ¼®(-2031³â)
Orexin Antagonist Market Report: Trends, Forecast and Competitive Analysis to 2031
¹ßÇà 2025³â 09¿ù
°¡°Ý
US $ 3,850
![]() |
![]() |
¼¼°èÀÇ ¸Þ´Ñ ¾ïÁ¦Á¦ ½ÃÀå : °¡°Ý, ¸ÅÃâ, ÀÓ»ó½ÃÇè µ¿Çâ(2028³â)
Global Menin Inhibitors Drug Market, Price, Sales & Clinical Trials Insight 2028
¹ßÇà 2025³â 09¿ù
°¡°Ý
US $ 2,800
![]() |
![]() |
KAT6 ¾ïÁ¦Á¦ ½ÃÀå ±Ô¸ð, Ç¥Àû Áý´Ü, °æÀï ±¸µµ, ½ÃÀå ¿¹Ãø(2040³â)
KAT6 Inhibitors Market Size, Target Population, Competitive Landscape, and Market Forecast - 2040
¹ßÇà 2025³â 09¿ù
°¡°Ý
US $ 7,950
![]() |
![]() |
IBAT ¾ïÁ¦Á¦(ȸÀå ´ãÁó»ê ¼ö¼Ûü ¾ïÁ¦Á¦) ½ÃÀå - Ç¥Àû Áý´Ü, °æÀï ±¸µµ, ½ÃÀå ¿¹Ãø(2034³â)
IBAT inhibitors (Ileal bile acid transporter Inhibitors) - Target Population, Competitive Landscape, and Market Forecast - 2034
¹ßÇà 2025³â 09¿ù
°¡°Ý
US $ 7,950
![]() |
![]() |
¶óÀ̽ŠŻ¸ÞÆ¿ÈÈ¿¼Ò 1(LSD1)- Ç¥Àû Áý´Ü, °æÀï ±¸µµ, ½ÃÀå ¿¹Ãø(2034³â)
Lysine demethylase 1 (LSD1) - Target Population, Competitive Landscape, and Market Forecast - 2034
¹ßÇà 2025³â 09¿ù
°¡°Ý
US $ 7,950
![]() |
![]() |
SMARCA ºÐÇØÁ¦ ½ÃÀå - Ç¥Àû Áý´Ü, °æÀï ±¸µµ, ½ÃÀå ¿¹Ãø(2034³â)
SMARCA Degrader - Target Population, Competitive Landscape, and Market Forecast - 2034
¹ßÇà 2025³â 09¿ù
°¡°Ý
US $ 7,950
![]() |
![]() |
Á¾¾ç ħÀ±¼º ¸²ÇÁ±¸(TIL) Ä¡·á¹ý - Ç¥Àû Áý´Ü, °æÀï ±¸µµ, ½ÃÀå ¿¹Ãø(2034³â)
Tumor-Infiltrating Lymphocyte (TIL) Therapies - Target Population, Competitive Landscape, and Market Forecast - 2034
¹ßÇà 2025³â 09¿ù
°¡°Ý
US $ 7,950
![]() |